Laparoscopic roux-en-y gastric bypass versus sleeve gastrectomy for obese patients with type 2 diabetes: A meta-analysis of randomized controlled trials

American Surgeon

Volumn 81, Issue 2, 2015, Pages 166-171

  Wang, Man Cai ^a   Guo, Xiao Hu ^a   Zhang, Yawu ^a   Zhang, Yu Long ^a   Zhang, Hui Han ^a   Zhang, You Cheng ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT CHANGE; COMPLICATION; GASTRECTOMY; LAPAROSCOPY; OBESITY, MORBID; PROCEDURES; STOMACH BYPASS;

DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925581325     PISSN: 00031348     EISSN: 15559823     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2-7 million participants. Lancet 2011;378:31-40.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
3. Tuner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-12.
4. Dixon JB, OBrien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-23.
5. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med 2009;122:248-56.
6. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev 2012;13:316-28.
7. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-85.
8. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50.
9. Nocca D, Guillaume F, Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg 2011;21:738-43.
10. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010;24:1005-10.
11. Desiderio J, Trastulli S, Scalercio V, et al. Laparoscopic sleeve gastrectomy and medical management for the treatment of type 2 diabetes mellitus in non-morbidly obese patients: a singlecenter experience. Diabetes Technol Ther 2013;15:281-8.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
13. Higgins JPT, Altman DG, Sterne JAC. Cochrane Handbook for Systematic Reviews of Interventions: Assessing Risk of Bias in Included Studies. 2011. Available at: http://handbook.cochrane.org/. Accessed September 20, 2013.
14. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-76.
15. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs. sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011;46:143-8.
16. Li XX. The Effectiveness of Sleeve Gastrectomy vs. Roux-en-y Gastric Bypass for Morbidly Obese Patients with Diabetes Mellitus. Shanghai, China: Second Military Medical University; 2008:1-124.
17. Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia 2013;56:1914-8.
18. Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev 2009;2:CD003641.
19. Vetter ML, Ritter S, Wadden TA, et al. Comparison of bariatric surgical procedures for diabetes remission: efficacy and mechanisms. Diabetes Spectr 2012;25:200-10.
20. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2008;19:1605-11.
21. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006;9:497-507.
22. Desiderio J, Trastulli S, Scalercio V, et al. Laparoscopic sleeve gastrectomy and medical management for the treatment of type 2 diabetes mellitus in non-morbidly obese patients: a singlecenter experience. Diabetes Technol Ther 2013;15:1-8.
23. Gill RS, Birch DW, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 2010;6:707-13.